Arovella Therapeutics Ltd
ASX:ALA
Prices of ASX stocks are not being updated. The latest ALA price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arovella Therapeutics Ltd
ASX:ALA
|
AU |
|
Maxim Power Corp
TSX:MXG
|
CA |
|
Wilh Wilhelmsen Holding ASA
F:WML2
|
NO |
|
V
|
Vilkyskiu Pienine AB
XMUN:UDW
|
LT |
|
Malu Paper Mills Ltd
NSE:MALUPAPER
|
IN |
|
Ternium SA
NYSE:TX
|
LU |
|
H
|
Hims Co Ltd
KOSDAQ:238490
|
KR |
|
T
|
Tabcorp Holdings Ltd
DUS:THL
|
AU |
|
V
|
VF Corp
DUS:VFP
|
US |
|
C
|
Coloplast A/S
F:CBHD
|
DK |
|
F
|
First Tellurium Corp
CNSX:FTEL
|
CA |
|
Proact IT Group AB
F:PIU0
|
SE |
|
UniCredit SpA
F:CRIP
|
IT |
|
V
|
VerticalScope Holdings Inc
TSX:FORA
|
CA |
|
D
|
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
|
KR |
|
C
|
Corestemchemon Inc
KOSDAQ:166480
|
KR |
|
Fujitsu Ltd
F:FUJA
|
JP |
|
A
|
ArcelorMittal SA
SWB:ARRD
|
LU |
|
Cuscal Ltd
F:Y49
|
AU |
|
Enagas SA
MAD:ENG
|
ES |
Bankruptcy Probability
Arovella Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Arovella Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Arovella Therapeutics Ltd
ASX:ALA
|
64.1m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
662.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
390.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
361.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
202.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
257.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
170.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Arovella Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Arovella Therapeutics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.